Year |
Citation |
Score |
2018 |
Hao Y, Song J, Ravikrishnan A, Dicker KT, Fowler EW, Zerdoum AB, Li Y, Zhang H, Rajasekaran AK, Fox JM, Jia X. Rapid Bioorthogonal Chemistry Enables in Situ Modulation of Stem Cell Behavior in 3D without External Triggers. Acs Applied Materials & Interfaces. PMID 30015482 DOI: 10.1021/Acsami.8B07632 |
0.328 |
|
2016 |
Hao Y, Zerdoum AB, Stuffer AJ, Rajasekaran AK, Jia X. Biomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide to Promote the 3D Assembly of Tumoroids. Biomacromolecules. PMID 27723964 DOI: 10.1021/Acs.Biomac.6B01266 |
0.335 |
|
2016 |
Ravikrishnan A, Ozdemir T, Bah MA, Baskerville KA, Shah SI, Rajasekaran AK, Jia X. Regulation of Epithelial-to-Mesenchymal Transition Using Biomimetic Fibrous Scaffolds. Acs Applied Materials & Interfaces. PMID 27322677 DOI: 10.1021/Acsami.6B05646 |
0.385 |
|
2015 |
David JM, Rajasekaran AK. Gramicidin A: A New Mission for an Old Antibiotic. Journal of Kidney Cancer and Vhl. 2: 15-24. PMID 28326255 DOI: 10.15586/Jkcvhl.2015.21 |
0.312 |
|
2015 |
Patil PU, D'Ambrosio J, Inge LJ, Mason RW, Rajasekaran AK. Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR. Journal of Cell Science. 128: 4366-79. PMID 26483386 DOI: 10.1242/Jcs.173518 |
0.717 |
|
2015 |
Huynh TP, Barwe SP, Lee SJ, McSpadden R, Franco OE, Hayward SW, Damoiseaux R, Grubbs SS, Petrelli NJ, Rajasekaran AK. Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression. Plos One. 10: e0122442. PMID 25836370 DOI: 10.1371/Journal.Pone.0122442 |
0.375 |
|
2015 |
Patil P, Mason RW, Ambrosio JD, Rajasekaran AK. Abstract LB-032: Soluble E-cadherin as a microenvironmental factor that enhances tumor progression Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-032 |
0.425 |
|
2014 |
Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV, Rajasekaran AK. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. Plos One. 9: e102041. PMID 25025131 DOI: 10.1371/Journal.Pone.0102041 |
0.422 |
|
2014 |
David JM, Owens TA, Inge LJ, Bremner RM, Rajasekaran AK. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma. Molecular Cancer Therapeutics. 13: 788-99. PMID 24493697 DOI: 10.1158/1535-7163.Mct-13-0891 |
0.7 |
|
2014 |
Selvakumar P, Owens TA, David JM, Petrelli NJ, Christensen BC, Lakshmikuttyamma A, Rajasekaran AK. Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma. Epigenetics. 9: 579-86. PMID 24452105 DOI: 10.4161/Epi.27795 |
0.429 |
|
2013 |
David JM, Owens TA, Barwe SP, Rajasekaran AK. Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells. Molecular Cancer Therapeutics. 12: 2296-307. PMID 24006494 DOI: 10.1158/1535-7163.Mct-13-0445 |
0.399 |
|
2013 |
David JM, Rajasekaran AK. Abstract 3451: Gramicidin-based nanopores induce cellular energy depletion and cell death in renal cell carcinoma. Cancer Research. 73: 3451-3451. DOI: 10.1158/1538-7445.Am2013-3451 |
0.388 |
|
2012 |
Barwe SP, Skay A, McSpadden R, Huynh TP, Langhans SA, Inge LJ, Rajasekaran AK. Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. Journal of Cell Science. 125: 5711-20. PMID 23077177 DOI: 10.1242/Jcs.108795 |
0.704 |
|
2012 |
David JM, Rajasekaran AK. Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Research. 72: 2917-23. PMID 22659456 DOI: 10.1158/0008-5472.Can-11-3498 |
0.385 |
|
2012 |
Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L1150-8. PMID 22345575 DOI: 10.1152/Ajplung.00384.2010 |
0.394 |
|
2011 |
Inge LJ, Barwe SP, D'Ambrosio J, Gopal J, Lu K, Ryazantsev S, Rajasekaran SA, Rajasekaran AK. Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Experimental Cell Research. 317: 838-48. PMID 21211535 DOI: 10.1016/J.Yexcr.2010.12.025 |
0.687 |
|
2010 |
Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, Ahmed MM, Leatherman JM, Mullin JM, Rajasekaran AK. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Molecular Cancer Therapeutics. 9: 1515-24. PMID 20501797 DOI: 10.1158/1535-7163.Mct-09-0832 |
0.767 |
|
2009 |
Barwe SP, Jordan MC, Skay A, Inge L, Rajasekaran SA, Wolle D, Johnson CL, Neco P, Fang K, Rozengurt N, Goldhaber JI, Roos KP, Rajasekaran AK. Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit. Journal of Molecular and Cellular Cardiology. 47: 552-60. PMID 19683723 DOI: 10.1016/J.Yjmcc.2009.07.018 |
0.718 |
|
2009 |
Tummala R, Wolle D, Barwe SP, Sampson VB, Rajasekaran AK, Pendyala L. Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. Cancer Chemotherapy and Pharmacology. 64: 1187-94. PMID 19322565 DOI: 10.1007/S00280-009-0985-X |
0.497 |
|
2009 |
Rajasekaran SA, Rajasekaran AK. Na,K-ATPase and epithelial tight junctions. Frontiers in Bioscience (Landmark Edition). 14: 2130-48. PMID 19273189 DOI: 10.2741/3367 |
0.384 |
|
2008 |
Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Molecular Cancer Therapeutics. 7: 2142-51. PMID 18645024 DOI: 10.1158/1535-7163.Mct-08-0005 |
0.72 |
|
2008 |
Inge LJ, Rajasekaran SA, Wolle D, Barwe SP, Ryazantsev S, Ewing CM, Isaacs WB, Rajasekaran AK. alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Molecular Cancer Therapeutics. 7: 1386-97. PMID 18566211 DOI: 10.1158/1535-7163.Mct-07-2029 |
0.748 |
|
2008 |
Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 117-24. PMID 18303430 DOI: 10.1097/Jto.0B013E3181622Bef |
0.682 |
|
2008 |
Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histology and Histopathology. 23: 459-67. PMID 18228203 DOI: 10.14670/Hh-23.459 |
0.763 |
|
2008 |
Rajasekaran SA, Beyenbach KW, Rajasekaran AK. Interactions of tight junctions with membrane channels and transporters. Biochimica Et Biophysica Acta. 1778: 757-69. PMID 18086552 DOI: 10.1016/J.Bbamem.2007.11.007 |
0.328 |
|
2008 |
Seligson DB, Rajasekaran SA, Yu H, Liu X, Eeva M, Tze S, Ball W, Horvath S, deKernion JB, Rajasekaran AK. Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. The Journal of Urology. 179: 338-45. PMID 18006011 DOI: 10.1016/J.Juro.2007.08.094 |
0.5 |
|
2007 |
Olson WC, Heston WDW, Rajasekaran AK. Clinical trials of cancer therapies targeting prostate-specific membrane antigen Reviews On Recent Clinical Trials. 2: 182-190. PMID 18474004 DOI: 10.2174/157488707781662724 |
0.384 |
|
2007 |
Goodman OB, Barwe SP, Ritter B, McPherson PS, Vasko AJ, Keen JH, Nanus DM, Bander NH, Rajasekaran AK. Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2. International Journal of Oncology. 31: 1199-203. PMID 17912448 DOI: 10.3892/Ijo.31.5.1199 |
0.353 |
|
2007 |
Barwe SP, Maul RS, Christiansen JJ, Anilkumar G, Cooper CR, Kohn DB, Rajasekaran AK. Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. International Journal of Oncology. 30: 899-904. PMID 17332929 DOI: 10.3892/Ijo.30.4.899 |
0.709 |
|
2007 |
Cui X, Zhang L, Luo J, Rajasekaran A, Hazra S, Cacalano N, Dubinett SM. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene. 26: 4253-60. PMID 17237818 DOI: 10.1038/Sj.Onc.1210222 |
0.35 |
|
2007 |
Barwe SP, Kim S, Rajasekaran SA, Bowie JU, Rajasekaran AK. Janus Model of The Na,K-ATPase β-Subunit Transmembrane Domain: Distinct Faces Mediate α/β Assembly and β-β Homo-oligomerization Journal of Molecular Biology. 365: 706-714. PMID 17078968 DOI: 10.1016/J.Jmb.2006.10.029 |
0.478 |
|
2007 |
Rajasekaran SA, Barwe SP, Gopal J, Ryazantsev S, Schneeberger EE, Rajasekaran AK. Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 292: G124-33. PMID 16959951 DOI: 10.1152/Ajpgi.00297.2006 |
0.426 |
|
2007 |
Reckamp KL, Gardner BK, Elashoff D, Figlin RA, Krysan K, Dohadwala M, Inge L, Rajasekaran A, Dubinett SM. P3-033: Serum biomarkers predict response to combination celecoxib and erlotinib therapy in advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S621. DOI: 10.1097/01.Jto.0000283790.42985.55 |
0.65 |
|
2006 |
Christiansen JJ, Weimbs T, Bander N, Rajasekaran AK. Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Molecular Cancer Therapeutics. 5: 2468-73. PMID 17041090 DOI: 10.1158/1535-7163.Mct-06-0253 |
0.714 |
|
2006 |
Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research. 66: 8319-26. PMID 16951136 DOI: 10.1158/0008-5472.Can-06-0410 |
0.693 |
|
2006 |
Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, Rajasekaran AK. Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvascular Research. 72: 54-61. PMID 16713605 DOI: 10.1016/J.Mvr.2006.03.004 |
0.73 |
|
2006 |
Liu W, Konduri SD, Bansal S, Nayak BK, Rajasekaran SA, Karuppayil SM, Rajasekaran AK, Das GM. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. The Journal of Biological Chemistry. 281: 9837-40. PMID 16469747 DOI: 10.1074/Jbc.C600001200 |
0.323 |
|
2005 |
Rajasekaran SA, Barwe SP, Rajasekaran AK. Multiple functions of Na,K-ATPase in epithelial cells. Seminars in Nephrology. 25: 328-34. PMID 16139688 DOI: 10.1016/J.Semnephrol.2005.03.008 |
0.475 |
|
2005 |
Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Molecular Cancer Therapeutics. 4: 704-14. PMID 15897234 DOI: 10.1158/1535-7163.Mct-04-0171 |
0.778 |
|
2005 |
Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? American Journal of Physiology. Cell Physiology. 288: C975-81. PMID 15840561 DOI: 10.1152/Ajpcell.00506.2004 |
0.712 |
|
2005 |
Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA, Rajasekaran AK. Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Molecular Biology of the Cell. 16: 1082-94. PMID 15616195 DOI: 10.1091/Mbc.E04-05-0427 |
0.489 |
|
2005 |
Kim G, Rajasekaran SA, Thomas G, Rosen EA, Landaw EM, Shintaku P, Lassman C, Said J, Rajasekaran AK. Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes. Histology and Histopathology. 20: 35-44. PMID 15578420 DOI: 10.14670/Hh-20.35 |
0.383 |
|
2004 |
Christiansen J, Rajasekaran AK. Biological impediments to monoclonal antibody-based cancer immunotherapy. Molecular Cancer Therapeutics. 3: 1493-501. PMID 15542788 |
0.651 |
|
2004 |
Rajasekaran SA, Gopal J, Espineda C, Ryazantsev S, Schneeberger EE, Rajasekaran AK. HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function. Pancreas. 29: e77-83. PMID 15367897 DOI: 10.1097/00006676-200410000-00016 |
0.754 |
|
2004 |
Rajasekaran SA, Gopal J, Willis D, Espineda C, Twiss JL, Rajasekaran AK. Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells. Molecular Biology of the Cell. 15: 3224-32. PMID 15133131 DOI: 10.1091/Mbc.E04-03-0222 |
0.779 |
|
2004 |
Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Molecular Biology of the Cell. 15: 1364-73. PMID 14699059 DOI: 10.1091/Mbc.E03-09-0646 |
0.791 |
|
2004 |
Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Laboratory Investigation; a Journal of Technical Methods and Pathology. 84: 8-20. PMID 14631378 DOI: 10.1038/Labinvest.3700003 |
0.306 |
|
2003 |
Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, Bander NH, Rajasekaran AK. A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen Molecular Biology of the Cell. 14: 4835-4845. PMID 14528023 DOI: 10.1091/Mbc.E02-11-0731 |
0.354 |
|
2003 |
Rajasekaran AK, Rajasekaran SA. Role of Na-K-ATPase in the assembly of tight junctions. American Journal of Physiology. Renal Physiology. 285: F388-96. PMID 12890662 DOI: 10.1152/Ajprenal.00439.2002 |
0.406 |
|
2003 |
Rajasekaran SA, Gopal J, Rajasekaran AK. Expression of Na,K-ATPase beta-subunit in transformed MDCK cells increases the translation of the Na,K-ATPase alpha-subunit. Annals of the New York Academy of Sciences. 986: 652-4. PMID 12763913 DOI: 10.1111/J.1749-6632.2003.Tb07277.X |
0.484 |
|
2003 |
Rajasekaran AK, Gopal J, Rajasekaran SA. Na,K-ATPase in the regulation of epithelial cell structure. Annals of the New York Academy of Sciences. 986: 649-51. PMID 12763912 DOI: 10.1111/J.1749-6632.2003.Tb07276.X |
0.42 |
|
2003 |
Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, Rajasekaran AK. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Research. 63: 2645-8. PMID 12750292 |
0.312 |
|
2003 |
Espineda C, Seligson DB, James Ball W, Rao J, Palotie A, Horvath S, Huang Y, Shi T, Rajasekaran AK. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 97: 1859-68. PMID 12673711 DOI: 10.1002/Cncr.11267 |
0.785 |
|
2003 |
Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. The Prostate. 55: 9-19. PMID 12640656 DOI: 10.1002/Pros.10203 |
0.716 |
|
2003 |
Rajasekaran SA, Hu J, Gopal J, Gallemore R, Ryazantsev S, Bok D, Rajasekaran AK. Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. American Journal of Physiology. Cell Physiology. 284: C1497-507. PMID 12570983 DOI: 10.1152/Ajpcell.00355.2002 |
0.415 |
|
2001 |
Rajasekaran SA, Palmer LG, Moon SY, Peralta Soler A, Apodaca GL, Harper JF, Zheng Y, Rajasekaran AK. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Molecular Biology of the Cell. 12: 3717-32. PMID 11739775 DOI: 10.1091/Mbc.12.12.3717 |
0.431 |
|
2001 |
Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ, Bander NH, Peralta Soler A, Rajasekaran AK. Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Molecular Biology of the Cell. 12: 279-95. PMID 11179415 DOI: 10.1091/Mbc.12.2.279 |
0.534 |
|
1999 |
Rajasekaran SA, Ball WJ, Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. The Journal of Urology. 162: 574-80. PMID 10411090 DOI: 10.1016/S0022-5347(05)68629-6 |
0.469 |
|
Show low-probability matches. |